Open randomized intergroup trial about efficacy and the safety of minodronate raloxifene and eldecalcitol in the drug choice after teriparatide 24 months administration for osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Minodronic acid (Primary) ; Eldecalcitol; Raloxifene
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 10 Apr 2013 New trial record